138 related articles for article (PubMed ID: 8358193)
1. Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis.
Ker CG; Sheen PC; Chien CH; Wu CC
Surg Today; 1993; 23(6):496-9. PubMed ID: 8358193
[TBL] [Abstract][Full Text] [Related]
2. A study of CEA, CA 19-9 and CA 125 in biliary tract diseases.
Ker CG; Wu CC; Chen JS; Hou MF; Lee KT; Sheen PC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Feb; 5(2):107-13. PubMed ID: 2733069
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
[TBL] [Abstract][Full Text] [Related]
4. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
Chen CY; Shiesh SC; Tsao HC; Lin XZ
Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
[TBL] [Abstract][Full Text] [Related]
5. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
6. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
Terada T; Nakanuma Y
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
[TBL] [Abstract][Full Text] [Related]
7. 'Metaplastic lesions' in intrahepatic bile ducts in hepatolithiasis: a histochemical and immunohistochemical study.
Kurumaya H; Terada T; Nakanuma Y
J Gastroenterol Hepatol; 1990; 5(5):530-6. PubMed ID: 2129825
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
[TBL] [Abstract][Full Text] [Related]
9. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.
Nakanuma Y; Terada T; Tanaka Y; Ohta G
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):45-58. PubMed ID: 2986349
[TBL] [Abstract][Full Text] [Related]
10. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen (CEA) and CEA-related substances in the bile of patients with biliary diseases.
Uchino R; Kanemitsu K; Obayashi H; Hiraoka T; Miyauchi Y
Am J Surg; 1994 Mar; 167(3):306-8. PubMed ID: 8160902
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
13. The role of bile carcinoembryonic antigen in diagnosing bile duct cancer.
Joo KR; Kim DH; Park JH; Bang SJ; Shin JW; Park NH; Park JH
J Korean Med Sci; 2003 Dec; 18(6):855-8. PubMed ID: 14676443
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma.
Sasaki M; Tsuneyama K; Nakanuma Y
Lab Invest; 2003 Oct; 83(10):1403-13. PubMed ID: 14563942
[TBL] [Abstract][Full Text] [Related]
15. [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects].
Yano Y
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1432-42. PubMed ID: 3537682
[TBL] [Abstract][Full Text] [Related]
16. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis.
Ohta T; Nagakawa T; Ueda N; Nakamura T; Akiyama T; Ueno K; Miyazaki I
Cancer; 1991 Nov; 68(10):2217-23. PubMed ID: 1655206
[TBL] [Abstract][Full Text] [Related]
17. [Intrahepatic biliary gland proliferation its relation to acute and chronic cholangitis in hepatolithiasis].
Chen YL
Zhonghua Wai Ke Za Zhi; 1993 Jan; 31(1):37-9. PubMed ID: 8404341
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.
Lee KT; Sheen PC
Dig Dis Sci; 1999 Nov; 44(11):2251-6. PubMed ID: 10573370
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma.
Yamashita K; Yonezawa S; Tanaka S; Shirahama H; Sakoda K; Imai K; Xing PX; McKenzie IF; Hilkens J; Kim YS
Int J Cancer; 1993 Aug; 55(1):82-91. PubMed ID: 8393843
[TBL] [Abstract][Full Text] [Related]
20. [A case of preoperatively diagnosed cholangiocarcinoma associated with hepatolithiasis].
Shinagawa T; Isomura S; Hirota K; Ukaji H; Kitagawa K; Ishizuka S; Uesawa K; Tsuchiya Y; Ohto M; Ryu M
Nihon Shokakibyo Gakkai Zasshi; 1984 Jul; 81(7):1642-6. PubMed ID: 6092748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
